Relevant bibliographies by topics / Prostate cancer screening

Academic literature on the topic 'Prostate cancer screening'

Author: Grafiati
Published: 4 June 2021
Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Prostate cancer screening.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Prostate cancer screening"

1

Kurator, Kevin, and Ian Jenkins. "Prostate cancer screening." Cleveland Clinic Journal of Medicine 88, no. 5 (May 2021): 260.2–260. http://dx.doi.org/10.3949/ccjm.88c.05002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zhang, Sherry, and Ian Jenkins. "Prostate cancer screening." Cleveland Clinic Journal of Medicine 88, no. 5 (May 2021): 260.1–260. http://dx.doi.org/10.3949/ccjm.88c.05001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ackermann, R. J. "Prostate cancer screening." CA: A Cancer Journal for Clinicians 40, no. 3 (May 1, 1990): 190–92. http://dx.doi.org/10.3322/canjclin.40.3.190.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rodríguez-Carlin, Arquímedes, and Octavio Castillo. "Prostate cancer screening." Medwave 16, no. 06 (July 22, 2016): e6504-e6504. http://dx.doi.org/10.5867/medwave.2016.06.6504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Roetzheim, Richard G., and Arthur H. Herold. "PROSTATE CANCER SCREENING." Primary Care: Clinics in Office Practice 19, no. 3 (September 1992): 637–49. http://dx.doi.org/10.1016/s0095-4543(21)00943-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Peate, Ian. "Screening: prostate cancer." British Journal of Nursing 31, no. 6 (March 24, 2022): 303. http://dx.doi.org/10.12968/bjon.2022.31.6.303.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Faigen, Mark. "Prostate cancer screening." Medical Journal of Australia 199, no. 9 (November 2013): 585. http://dx.doi.org/10.5694/mja13.10827.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hall, R. R., and F. Alexander. "Prostate cancer screening." Journal of the Royal Society of Medicine 91, no. 9 (September 1998): 507. http://dx.doi.org/10.1177/014107689809100929.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sikaris, Ken. "Prostate cancer screening." Pathology 44, no. 2 (February 2012): 99–109. http://dx.doi.org/10.1097/pat.0b013e32834fbb2c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Catalona, William J. "Prostate cancer screening." BJU International 94, no. 7 (November 2004): 964–66. http://dx.doi.org/10.1111/j.1464-410x.2004.05187.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Prostate cancer screening"

1

Holt, Jim, and Fereshteh Gerayli. "Prostate Cancer Screening." Digital Commons @ East Tennessee State University, 2019. https://dc.etsu.edu/etsu-works/6471.

Full text
Abstract:
Whether to screen for prostate cancer in aging men is a topic that is fairly well researched, but recommendations are controversial, because the evidence supporting any recommendation is equivocal. The evidence clearly does not support routine screening of all average-risk men, but for men aged 55 to 69 years, either not routinely screening, or engaging each man in shared decision making for his individual preference on screening, is reasonable and consistent with the evidence. Many organizations, including the American Cancer Society, have not yet reassessed their guidelines, in response to the US Preventative Services Task Force revised guideline.
APA, Harvard, Vancouver, ISO, and other styles
2

Thorn, Shirley A. "Prostate cancer, the screening conundrum." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0003/MQ32265.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lawson, Deborah A. "Prostate cancer screening practices of Missouri physicians /." free to MU campus, to others for purchase, 1998. http://wwwlib.umi.com/cr/mo/fullcit?p9901254.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Goeb, Katja Elisabeth. "MRI-spectroscopy in screening for prostate cancer /." Erlangen, 2008. http://opac.nebis.ch/cgi-bin/showAbstract.pl?sys=000253829.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ilyuk, I. I. "Metastatic prostate cancer. Prostate specific antigen as a screening marker of metastasing." Thesis, БДМУ, 2020. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18163.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Moore, Quentin E. "DEVELOPING A PREDICTIVE MODEL FOR PROSTATE CANCER SCREENING INTENT." UKnowledge, 2018. https://uknowledge.uky.edu/nursing_etds/35.

Full text
Abstract:
African Americans bear a disproportionately high burden of cancer incidence and mortality in this country. The purpose of this dissertation was to investigate factors associated with African-American men, who are incarcerated, making informed health decisions about participation in prostate cancer screening, as well as exploring factors that reduce modifiable risk factors for cancer. The United States incarcerates more people per capita than any country in the world and African American men are overrepresented in the U.S. prison system This dissertation is composed of three manuscripts. The first paper reviews the current literature about the factors that influence African-American males in making informed decisions about whether to participate in prostate cancer screening. The second paper uses existing data from a sample of 129 incarcerated African American men to examine the value of an intervention aimed at reducing modifiable risks for cardiovascular disease – and by extension, cancer – in inmates. The third paper explores predictors of intent to screen (or not) for prostate cancer in incarcerated African-American males, as well as those factors that influence informed decision-making in this population. These papers provide an overview of factors that influence incarcerated African-American men’s health decisions (health literacy, having a relative with previous diagnosis). These findings can be used to guide future research that addresses African-American male decision-making about personal health outcomes.
APA, Harvard, Vancouver, ISO, and other styles
7

Roemeling, Stijn. "Screening for prostate cancer intermediate outcome measures and active surveillance /." [S.l.] : Rotterdam : [The Author] ; Erasmus University [Host], 2007. http://hdl.handle.net/1765/10628.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Oliver, JoAnn Simon. "Prostate Cancer Screening Patterns among African American Men in the Rural South." Digital Archive @ GSU, 2008. http://digitalarchive.gsu.edu/nursing_diss/7.

Full text
Abstract:
Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among men in the United States. In African American men, the disease is typically detected at a more advanced stage and mortality is twice the rate of Caucasian men. However, African American men are less likely to participate in prostate cancer screening. The purpose of this descriptive study was to assess the relationship between health beliefs, knowledge, and selected demographic variables (age, income and education) and a man’s decision to participate in prostate cancer screening among African American men dwelling in rural communities. The conceptual framework for the study was the Health Belief Model. Participants for the study were recruited through contacts within rural communities within west central Alabama. A convenience sample of 90 African American men between the ages of 40-82 years of age was recruited. Analysis of the research data indicated that there was a statistically significant difference in motivation (health belief), knowledge, and age of men who participated in prostate cancer screening compared to those who did not participate in prostate cancer screening. Forward logistic regression was used to determine which independent variables [health beliefs (benefits, barriers, motivation); knowledge; age; income; and education] were predictors of prostate cancer screening. Results indicated the overall model of one predictor, motivation, was statistically reliable in predicting prostate cancer screening participation among the rural dwelling men surveyed. The model accounted for 15 to 20% of the variance. The sensitivity of the model in predicting those who would participate in prostate cancer screening was 85%. The odds of those who would participate in prostate cancer screening were 1.3 times greater for each one unit increase in motivation. Results indicate a need for more educational and motivational interventions to promote informed decision making by African American men in regards to prostate screening activities. These interventions need to be culturally sensitive and geared toward African American men, specifically those living in rural areas.
APA, Harvard, Vancouver, ISO, and other styles
9

McIntosh, Yeatoe G. "The Relationship between Perceived Personal Risk of getting Prostate cancer and Prostate-Specific Antigen (PSA) Screening." VCU Scholars Compass, 2008. http://scholarscompass.vcu.edu/etd/1579.

Full text
Abstract:
Abstract Title: The Relationship between Perceived Personal Risk of getting Prostate cancer and Prostate-Specific Antigen (PSA) Screening Yeatoe G. McIntosh, MPH Candidate Advisor: Emmanuel Anum, MBChB, MPH, PHD Preceptor: Emmanuel Anum, MBChB, MPH, PHD Background: Prostate cancer is one of the most common cancer diagnoses in the United States. The American Cancer Society estimates that in 2008 28,660 deaths would be attributed to prostate cancer, projecting it to be the leading cause of cancer deaths in U.S. men. Despite the potential threat this cancer presents to men and the potential for improved disease outcomes from early detection, guidelines for screening for prostate cancer are varied, and disparities in screening prevalence exist. In addition, disparities in knowledge about prostate cancer screening and misconceptions about the disease seem widespread. The main purpose of this study was to determine the relationship between perceived personal risk of getting prostate cancer and prostate cancer screening with the Prostate-specific antigen (PSA) test. Methods: Data were collected from the 2003 Health Information National Trends Survey (HINTS). Overall, 1,815 men ages 35 and above were included in the sample after exclusion of men ages 18-34. Logistic regression analyses were conducted to assess the association between perceived personal risk and prostate cancer screening with PSA test, while testing for interaction and further adjusting for possible confounders. A reduced model, in which variables with non-significant Wald chi-squared statistic had been excluded, was compared to the full model to access the change in parameter estimates. Using the model-based approach, we compared models with interaction terms to the one without interaction terms using the likelihood ratio test. Parameter estimates from the best fitting model were reported using the design-based method. SAS version 9.1 statistical software was used for analyses. Results: Among men ages 35-49, those who perceived their risk as high, were significantly less likely to screen than those who perceived their risk as low (OR: 0.20 95% CI: 0.05-0.78). Within ages 50-64 and 65 and above, there were no significant differences between perceived risk levels and PSA testing. Men, who did receive healthcare provider recommendation for screening, were more likely to obtain prostate cancer (PSA) screening than men who did not receive such recommendation (OR: 92.56 95% CI 36.56, 234.36). Conclusions: The relationship between perceived personal risk of getting prostate cancer and PSA screening is modified by age. As men aged, their odds of screening increased. The most significant predictor of PSA screening was health provider recommendation. PSA screening showed no association with either race or household income.
APA, Harvard, Vancouver, ISO, and other styles
10

Mitra, Anita. "Prostate cancer and targeted screening in BRCA1 and BRCA2 Mutation carriers." Thesis, Institute of Cancer Research (University Of London), 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.509785.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Prostate cancer screening"

1

1954-, Thompson Ian M., Resnick Martin I, and Klein Eric A. 1955-, eds. Prostate cancer screening. Totowa, N.J: Humana Press, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Prostate cancer screening. 2nd ed. New York, NY: Humana Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Thompson, Ian M., Martin I. Resnick, and Eric A. Klein. Prostate Cancer Screening. New Jersey: Humana Press, 2001. http://dx.doi.org/10.1385/1592590993.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ankerst, Donna P., Catherine M. Tangen, and Ian M. Thompson, eds. Prostate Cancer Screening. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-281-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Frödin, Jan-Erik. Mass screening for prostate cancer. New York: Published for the UICC by Wiley-Liss, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

United States. Congress. Office of Technology Assessment., ed. Costs and effectiveness of prostate cancer screening in elderly men. Washington, DC: The Office, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sara, Selley, Harvey Ian 1956-, and University of Bristol. Health Care Evaluation Unit., eds. Diagnosis, management and screening for early localised prostate cancer: A systematic review. Bristol: Department of Social Medicine, University of Bristol, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Salowe, Allen E. Prostate cancer: Overcoming denial with action : a guide to treatment, screening, and healing. St. Louis, Mo: Quality Medical Pub., 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Prostate cancer: New questions about screening and treatment : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Eleventh Congress, second session, March 4, 2010. Washington: U.S. G.P.O., 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Fund, Milbank Memorial, ed. Educated guesses: Making policy about medical screening tests. Berkeley: University of California Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Prostate cancer screening"

1

Schröder, Fritz H. "Prostate Cancer." In Cancer Screening, 461–514. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9780429179587-21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Philippou, Yiannis, Harveer Dev, and Prasanna Sooriakumaran. "Diagnosis and Screening." In Prostate Cancer, 16–33. Chichester, UK: John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118347379.ch2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Miller, Anthony B. "Prostate Cancer Screening." In Cancer and Aging Handbook, 153–61. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118312513.ch12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Miller, Anthony B. "Prostate Cancer Screening." In Epidemiologic Studies in Cancer Prevention and Screening, 277–85. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5586-8_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rifkin, Erik, and Andrew Lazris. "Prostate Cancer Screening." In Interpreting Health Benefits and Risks, 51–61. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-11544-3_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Potts, Jeannette M. "Prostate Cancer Screening." In Men's Health, 173–85. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3237-5_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shariat, Shahrokh F., and Michael W. Kattan. "Nomograms for Prostate Cancer." In Prostate Cancer Screening, 117–80. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-281-0_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Etzioni, Ruth, Roman Gulati, and Angela Mariotto. "Overview of US Prostate Cancer Trends in the Era of PSA Screening." In Prostate Cancer Screening, 3–14. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-281-0_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chun, Felix K. H., and Pierre I. Karakiewicz. "Decision Aid Criteria and Artificial Neural Networks for Optimizing Prostate Cancer Risk Prediction." In Prostate Cancer Screening, 181–93. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-281-0_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ankerst, Donna P., and Ian M. Thompson. "Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator." In Prostate Cancer Screening, 195–203. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-281-0_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Prostate cancer screening"

1

Yermolenko, S. B., D. I. Voloshynskyy, and O. S. Fedoruk. "Screening spectroscopy of prostate cancer." In 12th International Conference on Correlation Optics, edited by Oleg V. Angelsky. SPIE, 2015. http://dx.doi.org/10.1117/12.2228803.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chen, Yunjie, Liangbin Zhang, Wenjun Ma, Su Zhang, Fen Gao, Yunkai Zhu, and Yaqing Chen. "Cancer lesion screening in MRI for prostate biopsy." In 2016 IEEE 13th International Conference on Signal Processing (ICSP). IEEE, 2016. http://dx.doi.org/10.1109/icsp.2016.7877789.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Taylor, Kathryn L. "Abstract CN05-05: Decision making in prostate cancer screening." In Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Nov 7-10, 2010; Philadelphia, PA. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1940-6207.prev-10-cn05-05.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kagohara, Luciane T., Prakash Kulkarni, Takumi Shiraishi, Robert Vessella, Robert W. Veltri, and Elana J. Fertig. "Abstract 4525: Cancer/testis antigens: A biomarker panel for prostate cancer screening." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-4525.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Graff, Rebecca E., Thomas J. Hoffmann, Michael N. Passarelli, Nima C. Emami, Lori C. Sakoda, Eric Jorgenson, Laurel A. Habel, et al. "Abstract 1297: Genetic reclassification of prostate-specific antigen levels for personalized prostate cancer screening." In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-1297.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Imada, Eddie Luidy, Diego Fernando Sanchez, Wikum Dinalankara, Tamara Lotan, and Luigi Marchionni. "Abstract 2535: Screening PTEN-loss associated lncRNAs in prostate cancer." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-2535.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Peters, Cheryl, Paul Villeneuve, Sabrina Ladak, and Marie-Elise Parent. "P193 Occupation as a predictor of prostate cancer screening behaviour." In Occupational Health: Think Globally, Act Locally, EPICOH 2016, September 4–7, 2016, Barcelona, Spain. BMJ Publishing Group Ltd, 2016. http://dx.doi.org/10.1136/oemed-2016-103951.510.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"Case series: Breast and ovarian cancer syndrome." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685364.

Full text
Abstract:
Aims and Objectives: To report a series of cases with breast and ovarian carcinomas either in same patient or in a family and identifying the importance of BRCA 1, 2 genetic testing in such individuals. Materials and Methods: The medical records of breast and ovarian cancer patients operated over past 3 years at a single institute were reviewed retrospectively and their clinical profile, family history, final pathological reports and follow up data was collected. Results: 8 patients were found to have breast and ovarian malignancies, out of which 3 had synchronous breast and ovarian cancers, 4 had metachronous and 1 patient with ovarian cancer had history of breast cancer in family. Median age of presentation to the hospital was 47 years and median time interval in metachronous disease patients was 5.5 years. Conclusion: About 5% of people who have breast cancer and about 10% of women who have ovarian cancer have HBOC, caused by germline mutation in BRCA 1, 2 gene. These individuals have increased risk of developing breast cancer at younger age, TNBC, or developing a second primary in breast or ovary plus an overall risk of breast/ovarian/prostate/pancreatic malignancies in other family members due to inheritable mutation. Identification of BRCA mutation in such individuals can help family members to undergo genetic counseling and follow different screening and prevention guidelines from general population thus reducing the cancer risks.
APA, Harvard, Vancouver, ISO, and other styles
9

"Case series: Breast and ovarian cancer syndrome." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685348.

Full text
Abstract:
Aims and Objectives: To report a series of cases with breast and ovarian carcinomas either in same patient or in a family and identifying the importance of BRCA 1,2 genetic testing in such individuals. Materials and Methods: The medical records of breast and ovarian cancer patients operated over past 3 years at a single institute were reviewed retrospectively and their clinical profile, family history, final pathological reports and follow up data was collected. Results: 8 patients were found to have breast and ovarian malignancies, out of which 3 had synchronous breast and ovarian cancers, 4 had metachronous and 1 patient with ovarian cancer had history of breast cancer in family. Median age of presentation to the hospital was 47 years and median time interval in metachronous disease patients was 5.5 years. Conclusion: About 5% of people who have breast cancer and about 10% of women who have ovarian cancer have HBOC, caused by germline mutation in BRCA1, 2 gene. These individuals have increased risk of developing breast cancer at younger age, TNBC, or developing a second primary in breast or ovary plus an overall risk of breast/ovarian/prostate/pancreatic malignancies in other family members due to inheritable mutation. Identification of BRCA mutation in such individuals can help family members to undergo genetic counseling and follow different screening and prevention guidelines from general population thus reducing the cancer risks.
APA, Harvard, Vancouver, ISO, and other styles
10

Powell, Isaac J. "Abstract IA10: Risk and appropriate screening of African-Americans for prostate cancer." In Abstracts: AACR Special Conference: Prostate Cancer: Advances in Basic, Translational, and Clinical Research; December 2-5, 2017; Orlando, Florida. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.prca2017-ia10.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Prostate cancer screening"

1

Taylor, Kathryn L. Internet-Based Education for Prostate Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, December 2008. http://dx.doi.org/10.21236/ada494434.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Taylor, Kathryn L. Internet-Based Education for Prostate Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, December 2006. http://dx.doi.org/10.21236/ada462681.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Taylor, Kathryn L. Internet-Based Education for Prostate Cancer Screening. Fort Belvoir, VA: Defense Technical Information Center, December 2007. http://dx.doi.org/10.21236/ada481809.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Doukas, David J. Assessing Patient Values Towards Prostate Cancer Genetic Screening. Fort Belvoir, VA: Defense Technical Information Center, August 1999. http://dx.doi.org/10.21236/ada378059.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Roobol, Monique. Is screening for prostate cancer proven or justified? BJUI Knowledge, January 2022. http://dx.doi.org/10.18591/bjuik.0162.v2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zinn, Kurt R. A Specific Screening Strategy to Reduce Prostate Cancer Mortality. Fort Belvoir, VA: Defense Technical Information Center, September 2014. http://dx.doi.org/10.21236/ada611990.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Xu, Tian, and Betty Diamond. A Forward Genetic Screening for Prostate Cancer Progression Genes. Fort Belvoir, VA: Defense Technical Information Center, October 2012. http://dx.doi.org/10.21236/ada567776.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zinn, Kurt R. A Specific Screening Strategy to Reduce Prostate Cancer Mortality. Fort Belvoir, VA: Defense Technical Information Center, September 2013. http://dx.doi.org/10.21236/ada590686.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Price, Marva. Increasing Sustained Participation in Free Mass Prostate Cancer Screening Clinics. Fort Belvoir, VA: Defense Technical Information Center, May 2005. http://dx.doi.org/10.21236/ada443263.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hull, Pamela C. Psychosocial and Cultural Barriers to Prostate Cancer Screening: Racial Comparisons. Fort Belvoir, VA: Defense Technical Information Center, March 2008. http://dx.doi.org/10.21236/ada485653.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Prostate cancer screening' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography